Cargando…
Double antithrombotic therapy for prevention of bleeding and ischemic events after percutaneous coronary intervention in patients with atrial fibrillation: A meta-analysis
BACKGROUND: The efficacy of double antithrombotic therapy (DAT) vs. triple antithrombotic therapy (TAT) for prevention of bleeding and ischemic events in patients with atrial fibrillation following percutaneous coronary intervention (PCI) is unclear in those subgroups defined by the 5 factors (i.e.,...
Autores principales: | Qiu, Mei, Liu, Shu-Yan, Zhou, Hai-Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7793444/ https://www.ncbi.nlm.nih.gov/pubmed/33429808 http://dx.doi.org/10.1097/MD.0000000000024188 |
Ejemplares similares
-
Stroke prevention and guideline adherent antithrombotic treatment in elderly patients with atrial fibrillation: A real-world experience
por: Gorczyca, Iwona, et al.
Publicado: (2020) -
Stroke Event Rates and the Optimal Antithrombotic Choice of Patients With Paroxysmal Atrial Fibrillation: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Chen, Yicong, et al.
Publicado: (2015) -
Prediction of gastrointestinal bleeding events in patients with acute coronary syndrome undergoing percutaneous coronary intervention: An observational cohort study (STROBE compliant)
por: Zheng, Wen, et al.
Publicado: (2020) -
Left atrial deformation and risk of transient ischemic attack and stroke in patients with paroxysmal atrial fibrillation
por: Chen, Jian, et al.
Publicado: (2023) -
Bleeding events associated with fibrinolytic therapy and primary percutaneous coronary intervention in patients with STEMI: A systematic review and meta-analysis of randomized controlled trials
por: Bundhun, Pravesh Kumar, et al.
Publicado: (2016)